US Stock MarketDetailed Quotes
BPTH Bio-Path Holdings
- 3.120
- +1.060+51.45%
Trading Jun 3 11:27 ET
5.17MMarket Cap-123P/E (TTM)
4.550High3.050Low48.79MVolume4.050Open2.060Pre Close184.31MTurnover2952.09%Turnover RatioLossP/E (Static)1.66MShares44.80052wk High-1.97P/B5.16MFloat Cap1.85052wk Low--Dividend TTM1.65MShs Float23999.988Historical High--Div YieldTTM72.82%Amplitude1.850Historical Low3.777Avg Price1Lot Size
Bio-Path Holdings News
Bio-Path Hldgs Analyst Ratings
Bio-Path Hldgs Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Bio-Path Holdings (BPTH), Argenx Se (ARGX) and Revolution Medicines (RVMD)
H.C. Wainwright Reaffirms Their Buy Rating on Bio-Path Holdings (BPTH)
Bio-Path Holdings (BPTH) Gets a Buy From H.C. Wainwright
No More
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg